HCPCS Level II · Outpatient PPS (temporary codes)
C9168Injection, mirikizumab-mrkz, 1 mg
Terminated 06/30/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9168
C9168 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, mirikizumab-mrkz, 1 mg.
It was added to HCPCS effective 04/01/2024, and its current record took effect 07/01/2024.
It was terminated on 06/30/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Injection, mirikizumab-mrkz
- Date added
- 04/01/2024
- Action effective
- 07/01/2024
- Termination date
- 06/30/2024
- BETOS
- O1E
Related C91xx codes
Common questions about C9168
Is HCPCS C9168 still valid?
- No. C9168 was terminated on 06/30/2024.
Does Medicare cover C9168?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.